ROY F CHEMALY to Staphylococcal Infections
This is a "connection" page, showing publications ROY F CHEMALY has written about Staphylococcal Infections.
Connection Strength
0.913
-
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
Score: 0.283
-
Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol. 2010 Jun; 17(6):1499-506.
Score: 0.240
-
A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans. Clin Infect Dis. 2019 06 18; 69(1):167-178.
Score: 0.115
-
Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Support Care Cancer. 2017 04; 25(4):1063-1069.
Score: 0.096
-
Panton Valentine Leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Medicine (Baltimore). 2011 Sep; 90(5):312-318.
Score: 0.067
-
The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control. 2008 Nov; 36(9):656-60.
Score: 0.055
-
Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb; 27(2):195-7.
Score: 0.046
-
Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006 Mar; 85(2):86-94.
Score: 0.011